Skip Nav Destination
Issues
Editorial
The Biology Behind
Human Cancer Biology
Heregulin-Induced Activation of HER2 and HER3 Increases Androgen Receptor Transactivation and CWR-R1 Human Recurrent Prostate Cancer Cell Growth
Christopher W. Gregory; Young E. Whang; Wesley McCall; Xiaoyin Fei; Yuanbo Liu; Liliana A. Ponguta; Frank S. French; Elizabeth M. Wilson; H. Shelton Earp, III
Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs
Bernhard Frankenberger; Heike Pohla; Elfriede Noessner; Gerald Willimsky; Britta Papier; Antonio Pezzutto; Joachim Kopp; Ralph Oberneder; Thomas Blankenstein; Dolores J. Schendel
Imaging, Diagnosis, Prognosis
Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer
Tyvin Rich; Pasquale F. Innominato; Julie Boerner; M. Christine Mormont; Stefano Iacobelli; Benoit Baron; Claude Jasmin; Francis Lévi
Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas
Shin-ichi Fukumoto; Naoko Yamauchi; Hisashi Moriguchi; Yoshitaka Hippo; Akira Watanabe; Junji Shibahara; Hirokazu Taniguchi; Shumpei Ishikawa; Hirotaka Ito; Shogo Yamamoto; Hiroko Iwanari; Mitsugu Hironaka; Yuichi Ishikawa; Toshiro Niki; Yasunori Sohara; Tatsuhiko Kodama; Masaharu Nishimura; Masashi Fukayama; Hirotoshi Dosaka-Akita; Hiroyuki Aburatani
Prognostic Validation of the International Classification of Immunoglobulin M Gammopathies: A Survival Advantage for Patients with Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance?
Paolo G. Gobbi; Luca Baldini; Chiara Broglia; Maria Goldaniga; Mario Comelli; Pierre Morel; Enrica Morra; Sergio Cortelazzo; Roberto Bettini; Giampaolo Merlini
Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer
Kshama R. Mehta; Kentaro Nakao; Marlene B. Zuraek; Daniel T. Ruan; Emily K. Bergsland; Alan P. Venook; Dan H. Moore; Taku A. Tokuyasu; Ajay N. Jain; Robert S. Warren; Jonathan P. Terdiman; Frederic M. Waldman
Cancer Therapy: Clinical
Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer
Jeany M. Rademaker-Lakhai; Simon Horenblas; Willem Meinhardt; Ellen Stokvis; Theo M. de Reijke; José M. Jimeno; Luis Lopez-Lazaro; José A. Lopez Martin; Jos H. Beijnen; Jan H.M. Schellens
A Phase I Trial of the Novel Farnesyl Protein Transferase Inhibitor, BMS-214662, in Combination with Paclitaxel and Carboplatin in Patients with Advanced Cancer
Grace K. Dy; Laura M. Bruzek; Gary A. Croghan; Sumithra Mandrekar; Charles Erlichman; Prema Peethambaram; Henry C. Pitot; Lorelei J. Hanson; Joel M. Reid; Alfred Furth; Shinta Cheng; Robert E. Martell; Scott H. Kaufmann; Alex A. Adjei
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
Ian D. Davis; Lynette Kiers; Lachlan MacGregor; Michael Quinn; Joseph Arezzo; Michael Green; Mark Rosenthal; Michael Chia; Michael Michael; Peter Bartley; Leonie Harrison; Michael Daly
Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor
Carla M.L. van Herpen; Jeroen A.W.M. van der Laak; I. Jolanda M. de Vries; Johan H. van Krieken; Peter C. de Wilde; Michiel G.J. Balvers; Gosse J. Adema; Pieter H.M. De Mulder
A Phase I Study of α-Galactosylceramide (KRN7000)–Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
Aki Ishikawa; Shinichiro Motohashi; Eiichi Ishikawa; Hiroki Fuchida; Kazuko Higashino; Mizuto Otsuji; Toshihiko Iizasa; Toshinori Nakayama; Masaru Taniguchi; Takehiko Fujisawa
Cancer Therapy: Preclinical
Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity
Michela Spadaro; Elena Ambrosino; Manuela Iezzi; Emma Di Carlo; Pamela Sacchetti; Claudia Curcio; Augusto Amici; Wei-Zen Wei; Piero Musiani; Pier-Luigi Lollini; Federica Cavallo; Guido Forni
Farnesyltransferase Inhibitors and Human Malignant Pleural Mesothelioma: A First-Step Comparative Translational Study
Alfredo Cesario; Alessia Catassi; Luigi Festi; Andrea Imperatori; Andrea Pericelli; Domenico Galetta; Stefano Margaritora; Venanzio Porziella; Vittorio Cardaci; Pierluigi Granone; Lorenzo Dominioni; Patrizia Russo
Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
Bruce D. Cohen; Deborah A. Baker; Catherine Soderstrom; George Tkalcevic; Ann Marie Rossi; Penny E. Miller; Mark W. Tengowski; Faye Wang; Antonio Gualberto; Jean S. Beebe; James D. Moyer
Cancer Prevention
Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer
Davide Serrano; Laura Baglietto; Harriet Johansson; Frederique Mariette; Rosalba Torrisi; Marina Onetto; Michela Paganuzzi; Andrea Decensi
Advertisement
